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Background: Metabolic syndrome such as dyslipidemia, hypertension, obesity, impaired glucose tolerance and fatty
liver, can be caused by modification of diet by means of overconsumption of high fructose diet. This study was
designed to investigate whether combination with Red ginseng and Polygoni Multiflori Radix (RGPM), widely used
traditional herbal medicine, ameliorates on highfructose (HF) diet-induced metabolic syndrome.
Methods: SD rats were fed the 60 % HF diet with/without rosiglitazone, and RGPM 100, 300 mg/kg/day,
respectively. All groups received regular diet or HF diet, respectively, for 8 weeks. The last three groups treatment
of rosiglitazone and RPGM orally for a period of 6 weeks.
Results: Chronic treatment with RGPM significantly decreased body weight, fat weight and adipocyte size. RGPM
significantly prevented the development of the metabolic disturbances such as hypertension, hyperlipidemia and
impaired glucose tolerance. RGPM also led to increase in high density lipoprotein level in the HF group. RGPM
suppressed high-fructose diet induced vascular inflammation marker expression such as adhesion molecules and
ET-1 in aorta as well as increasing of C-reactive protein (CRP) levels in plasma. Similarly, RGPM attenuated hepatic
lipid accumulation by inhibition of monocyte chemoattractant protein-1 (MCP-1) expression.
Conclusion: An administration of RGPM may be a beneficial therapy for the treatment of metabolic syndrome
through the improvement of hypertension, obesity, hyperlipidemia, vascular inflammation and insulin resistance.
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Metabolic syndrome which is caused by disorder of sig-
nal delivery system of insulin hormone, such as insulin
resistance and glucose metabolism in muscles, tissues of
fat and liver. There are numerous people who have insu-
lin resistance before diabetes disease except type 2 dia-
betes. Also, it is well known as an important factor of
cardiovascular disease and stroke [1–3]. A damage of
vascular endothelial cell is known to be a decisive factor
of conditional pathophysiology of cardiovascular disease* Correspondence: dgkang@wku.ac.kr; host@wku.ac.kr
1College of Oriental Medicine and Professional Graduate School of Oriental
Medicine, Wonkwang University, Shinyong-dong, Iksan, Jeonbuk 570-749,
Korea
Full list of author information is available at the end of the article
© 2016 Kho et al. Open Access This article is
International License (http://creativecommons
reproduction in any medium, provided you g
the Creative Commons license, and indicate if
(http://creativecommons.org/publicdomain/zeas arteriosclerosis which is caused by secretion of cell ad-
hesion molecules, endothelin-1 (ET-1) and inflammatory
cytokine [4]. Especially, it is reported that vascular inflam-
mation which caused a disease with ischemia and necrosis
of tissues, also it has various symptoms by invasion of all
vascular not be related by a size, a location and a type
[5, 6]. In metabolic syndrome, the liver is profoundly af-
fected by excess dietary nutrients from the intestines
and inflammatory adipocytokines from enlarged visceral
adipose tissues. Thus, fatty liver is considered as a rep-
resentative of metabolic syndrome [7–9]. Nonalcoholic
fatty liver disease (NFLAD) induces a broad spectrum of
manifestation of fatty liver, ranging from steatosis alone,
steatosis with inflammation (stetohepatitis), steatosis
with hepatocyte injury, or steatosis with sinusoidal fi-
brosis in relation to the progress of the pathologicaldistributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
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on traditional medicines are interested for the prevented or
obstructed diseases of fatty liver, hypertension, high choles-
terol and diabetes. Thus, the demand has increased that an
interest of treatment effects has risen [11–13].
Red ginseng (RG), is produced by steaming and drying
fresh and raw ginseng. During the steaming process, ginse-
nosides produce chemical changes that confer the potential
to induce special physical activities [14]. Several studies
already reported that RG exhibits anti-inflammation, anti-
oxidant, anti-diabetes and anti-aging effects [15–18]. Poly-
goni Multiflori Radix (PM), is originated from the root of
Polygonum multiflorum Thunb, have many biological ac-
tivities such as anti-oxidant, anti-tumor, anti-aging and
regulate lipid metabolism [19, 20]. Those two herbs have
been used for more than 2000 years in Asia as a traditional
medicine and dietary supplement for health [21]. However,
the effect combination with Red ginseng and Polygoni Mul-
tiflori Radix on high fructose (HF) diet animal model has
not been yet reported. Thus, the present study was de-
signed to determine whether combination with Red ginseng
and Polygoni Multiflori Radix (RGPM) improves high fruc-
tose diet-induced metabolic syndrome.
Methods
Preparation of Red ginseng and Polygoni Multiflori Radix
The Red ginsengextract was purchased from the
Institute of Jinan Red ginseng, is a commercially avail-
able product (Jinan, Jeonbuk Province, Korea), and Poly-
goni Multiflori Radix was purchased from Herbal
Medicine Co-operative Association, Mujin, Jeonbuk
Province, Korea, respectively. A voucher specimen (No.
HBI141) was deposited in the herbarium of the Professional
Graduate School of Oriental Medicine, Wonkwang
University, Iksan, Jeonbuk, South Korea. The dried
Polygoni Multiflori Radix (400 g) was boiled with 4 L
of distilled water at 100 °C for 2 h. The extract was fil-
tered through Whatman No.3 filter paper (Whatman
International Ltd, England) and centrifuged at 990 × g for
20 min at 4 °C. Supernatant was concentrated using a rotary
evaporator and then the resulting extract (19.929 g) was ly-
ophilized by using a freeze-drier and retained at −70 °C
until required. The combination of Red ginseng and Poly-
goni Multiflori Radix was mixed at a ratio of 1:1.
Animal experiments and diet
All experimental procedures were carried out in accordance
with the National Institute of Health Guide for the Care
and Use of Laboratory Animals and were approved by the
Institutional Animal Care and Utilization Committee for
Medical Science of Wonkwang University. Seven week old
male Sprague–Dawley (SD) rats were obtained from
Samtako (Osan, Republic of Korea). All Rats were housed
in a room with an automatically maintained at atemperature (23 ± 2 °C), humidity (50 ~ 60 %) and 12-h
light/dark cycle throughout the experiments. After 1 week
of acclimatization, animals were randomly divided into
fivegroups (n = 10 per group), namely, (1) the control group
(SD rats + regular diet + distilled water), (2) High-fructose
control group (SD rats + 60 % HF diet + distilled water), (3)
positive control group (SD rat + 60 % HF diet + rosiglita-
zone 10 mg/kg/day), (4) combination with Red ginseng and
Polygoni Multiflori Radixgroup 1 (SD rats + 60 % HF diet +
RPGM 1 100 mg/kg/day), (5) combination with Red gin-
seng and Polygoni Multiflori Radixgroup 2 (SD rats + 60 %
HF diet + RPGM 2 300 mg/kg/day). The 60 % high fructose
diet (HF) was purchased from Research Diet, Inc. USA. All
groups received regular diet or HF diet, respectively, for
8 weeks. The last three groups treatment of rosiglitazone
and RPGM orally for a period of 6 weeks. The regular diet
was composed of 50 % starch, 21 % protein, 4 % fat and
standard vitamins and mineral mix. The high fructose diet
was composed of 60 % fructose, 20 % protein, 10 % fat and
standard vitamins and mineral mix.
Blood and tissue sampling
At the end of the experiments, the aorta, liver and adi-
pose tissue (epididymal fat pads) were separated, frozen
until analysis after rinsed with cold saline. The plasma
was obtained from the coagulated blood by centrifuga-
tion at 3000 rpm 15 min at 4 °C. The separation of
plasma was frozen at −80 °C until analysis.
Measurements of blood pressure
Systolic blood pressure (SBP) was determined by using
non-invasive tail-cuff plethysmogrphy method and re-
corded with an automatic sphygmotonography (MK2000;
Muromachi Kikai, Tokyo, Japan). SBP was measured at −1,
2, 5, and 8 week, respectively. At least seven determinations
were made in every session. Values were presented as the
mean ± SEM of four measurements.
Biochemical analysis of plasma lipids
The total cholesterol (T-Cho), high-density lipoprotein-
(HDL-) cholesterol, low-density lipoprotein- (LDL-) choles-
terol, triglyceride (TG), glutamic-oxaloacetic transaminase
(GOT) andglutamic-pyruvic transaminase (GPT) levels in
plasma were enzymatically measured using commercially
available kits (ARKRAY, Inc., Minami-ku, Kyoto, Japan).
The creactive protein (CRP) and leptin levels were mea-
sured based on ELISA method using commercial rat cre-
ative protein and leptin ELISA kit (Leptin Rat ELISA
ab100773, abcam).
Estimation of blood glucose and oral glucose tolerance
test
The concentration of glucose in blood was measured
which obtained from tail vein using glucometer
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The oral glucose tolerance test (OGTT) was per-
formed 2 days apart at 7 weeks. For the OGTT, briefly,
basal blood glucose concentrations were measured after
10 ~ 12 h of overnight food privation, then the glucose
solution (2 g/kg body weight) was immediately adminis-
tered via oral gavage, and fourth more tail vein blood
samples were taken at 30, 60, 90 and 120 min after glu-
cose administration.
Protein preparation and Western blot analysis in the rat
aorta and liver
Thoracic aorta and liver were homogenized in a buffer
consisting of 250 mM sucrose, 1 mM EDTA, 0.1 mM phe-
nylmethylsulfonyl fluoride, and 20 mM potassium phos-
phate buffer (pH 7.6). Large tissue debris and nuclear
fragments were removed by two successive low-speed
spins (3500 rpm, 5 min; 8000 rpm, 10 min, 4 °C). The re-
covered protein (40 μg) was separated by 10 % SDS-PAGE
and transferred electrophoretically to nitrocellulose mem-
branes using a Mini-Protean II apparatus (Bio-Rad,
Hercules, CA). Membranes were blocked with 5 % BSA
powder in 0.05 % Tween 20-Tris-bufferd saline (TBS-T)
for 1 h prior to incubation in the presence of primary
antibodies to E-selectin, VCAM-1, ICAM-1, PPAR-γ, and
β-actin (in aorta) and MCP-1 (in liver) (Santa Cruz
Biotechnology, Santa Cruz, CA) at a final dilution of
1:1000 overnight at 4 °C. The blot was washed several
times with TBS-T and incubated with the appropriate
horseradish peroxidase-conjugated secondary antibody for
1 h. After the membrane was washed several times with
TBS-T, incubated with horseradish peroxidase-conjugated
secondary antibody for 1 h, and then the immunoreactive
bands were visualized by using enhanced chemilumines-
cence (Amersham, Buchinghamshire, UK). The bands
were analyzed densitometrically by using a Chemi-doc
image analyzer (Bio-Rad, Hercules, CA, USA).
Histopathological staining ofepididymal fat
Epididymal fat and liver tissues were fixed by immersion
in 4 % paraformaldehyde for 48 h at 4 °C, and then incu-
bated with 30 % sucrose for 2 days. Each fat and liver
was embedded in OCT compound (Tissue-Tek, Sakura
Finetek, Torrance, CA, USA), frozen in liquid nitrogen,
and stored at −80 °C. Frozen sectionswere cut with a
Shandon Cryotome SME (Thermo Electron Corporation,
Pittsburg, PA, USA) and placed on poly-L-lysine-coated
slide. Epididymal fat sections were stained with H&E.
For quantitative histopathological comparisons, each
sections were determined by Axiovision 4 Imaging/
Archiving software (Axiovision 4, Carl Zeiss, Germany).
Liver sections were assessed by using Oil red O stain-
ing. Each sections were stained with Oil red O for20 min at room temperature after rinsing with 60 % iso-
propyl alcohol and distilled water. Images of Oil red O
stained liver were taken with a Axiovision 4 Imaging/
Archiving software. For quantitative analysis, the aver-
age score of 10 ~ 20 randomly selected area was calcu-
lated by using NIH Image analysis software, Image J
(NIH, Bethesda, MD, USA).
Immunihistochemical staining of aortic tissues
Aorta tissues were fixed by immersion in 4 % parafor-
maldehyde for 48 h at 4 °C, and then incubated with
30 % sucrose for 2 days. Each fat and liver was embed-
ded in OCT compound (Tissue-Tek, Sakura Finetek,
Torrance, CA, USA), frozen in liquid nitrogen, and
stored at −80 °C. Frozen sections for immunohistochem-
ical staining were placed on poly-L-lysine-coated slide
(Fisher scientific, Pittsburgh, PA, USA). Slides were
immunestained by Invitrogen’s HISOTO-STAIN®-SP kits
using the Labeled-[strept] Avidin-Biotin (LAB-SA)
method. After antigen retrieval, slide were immersed
in 3 % hydrogen peroxide for 10 min at room
temperature to block endogenous peroxidase activity,
and rinsed with PBS. After rinsed, slides were incu-
bated with 10 % non-immune goat serum for 10 min
at room temperature, and incubated with a primary
antibodies of ET-1, VCAM-1 and E-selectin (1:200;
Santa Cruz, CA, USA) in humidified chambers over-
night at 4 °C. All slides were then incubated with bio-
tinylated secondary antibody for 20 min at room
temperature, and then incubated with horseradish
peroxidase-conjugated streptavidin for 20 min at room
temperature. Peroxidase activity was visualized by 3-
amino-9-ethylcarbazole (AEC; Novex®, CA) substrate-
chromogen system, and counterstaining with hematoxylin
(Zymed, CA, USA). Images of aorta tissues were taken
with aAxiovision 4 Imaging/Archiving software. For quan-
titative analysis, the average score of 10 ~ 20 randomly se-
lected area was calculated by using NIH Image analysis
software, Image J (NIH, Bethesda, MD, USA).
Statistical analysis
All the experiments were repeated at least three times.
The results were expressed as a mean ± S.E. The data
was analyzed using SIGMAPLOT 10.0 program. The
Student’s t-test was performed to determine any signifi-
cant differences. P < 0.05 was considered as statistically
significant.
Results
Effects of RGPM on changes in body weight and
epididymal fat pads weight
At time of sacrifice, mean body weight was shown as in
Table 1, HF-diet rats showed significantly increased body
weight compared to control group. However, treatment
Table 1 Effect of RGPM on body weight and epididymal fat pads
Groups Cont. HF HF
Ros. RGPM 1 RGPM 2
Initial BW (g) 234.4 ± 1.2 236.9 ± 1.4 233.4 ± 2.1 234.4 ± 2.1 235.9 ± 2.1
Terminal BW (g) 418.0 ± 8.5 461.1 ± 10.6** 430.9 ± 6.0# 427.3 ± 8.0# 426.8 ± 9.2#
Gain BW (g) 183.7 ± 9.6 229.3 ± 11.7** 203.0 ± 5.1# 193.1 ± 5.8# 190.0 ± 8.0#
Epididymal fat pads weight (g) 6.1 ± 0.6 11.3 ± 0.7** 8.4 ± 0.9# 8.7 ± 0.7# 8.5 ± 0.9#
Values were expressed as mean ± S.E. (n = 10). **p < 0.01 vs. Cont.; #p < 0.05 vs HF. Abbreviations: HF high fructose, HF + Ros. high fructose diet with rosiglitazone,
HF + RGPM high fructose diet with Red ginseng and Polygoni Multiflori Radix, BW body weight
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weight compared to HF group. In addition, the overall
weight gain in HF group was significantly increased com-
pared to control group. However, treatment of RGPM
groups showed significant decrease in gain weight com-
pared to HF group.
Moreover, HF diet results in a significant increase
in epididymal fat pads weight. The weight of epididy-
mal fat pads was 84.57 % higher than that of the HF
diet group compared to control group. However,
treatment of RGPM groups significantly reduced the
epididymal fat pads weight (−46.73, −46.53 %) com-
pared to HF diet group, respectively. Similarly, treat-
ment of rosiglitazone was showed similar results with
RGPM groups.Fig. 1 Effects of RGPM on adipocytes in HF diet rats. Representative micros
HF diet rats. Lower panel indicated the size of adipose cells (magnification ×
#p < 0.05, ##p < 0.01 vs HF. Abbreviations: HF high fructose, HF + Ros. high fru
ginseng and PolygoniMultiflori Radix. a control; b HF; c HF+Ros.; d HF+RGPEffect of RGPM on the morphology ofepididymal fat pads
Because RGPM effectively reduced the epididymal fat pads
weight, we prepared frozen section of epididymal fat pads
and stained with H&E. Histological findings as shown in
Fig. 1 revealed hypertrophy of adipocytes in HF group
compared to control group (+84.70 %, P < 0.01). However,
treatment of RGPM groups showed significantly
decreased the hypertrophy of adipocytes (−24.87 and
−31.14 %, respectively, P < 0.05) (Fig. 1) compared to
HF group. Similarly, treatment of rosiglitazone was
showed similar results with RGPM groups.
Effect of RGPM on lipid and levels
The plasma triglycerides, total cholesterol, and LDL-
cholesterol levels were significantly increased in HF dietcopic photographs of H&E stained section of epididymal fat pads in
400). Values were expressed as mean ± S.E. (n = 4). **p < 0.01 vs Cont.;
ctose diet with rosiglitazone, HF + RGPM high fructose diet with Red
M21; e HF+RGPM 2
Table 2 Effect of RGPM on plasma lipid levels
Groups Control HF HF
Ros. RGPM 1 RGPM 2
T-Cho (mg/dl) 50.0 ± 2.0 8.5 ± 8.9** 51.8 ± 1.0## 66.3 ± 5.9 54.5 ± 39#
TG (mg/dl) 36.3 ± 5.8 240.8 ± 69.8* 107.8 ± 19.4 76.8 ± 16.6 181.8 ± 7.7
HDL-c (mg/dl) 24.0 ± 1.7 24.8 ± 0.8 31.5 ± l.2## 34.5 ± 2.9# 38.5 ± 3.8#
LDL-c (mg/dl) 14.5 ± 1.2 25.3 ± 3.0* 15.4 ± 3.5# 15.1 ± 2.8# 16.2 ± 1.4#
Values were expressed as mean ± S.E. (n = 10). *p < 0.05, **p < 0.01 vs. Cont.; #p < 0.05, ##p < 0.01 vs HF. Abbreviations: HF high fructose, HF + Ros. high fructose
diet with rosiglitazone, HF + RGPM high fructose diet with Red ginseng and Polygoni Multiflori Radix, T-Cho total cholesterol, TG triglyceride, HDL-c high-density
lipoprotein cholesterol, LDL-c low-density lipoprotein cholesterol
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analysis of blood samples ofRGPM2 groups showed sig-
nificant decrease of T-Cho and LDL-c when compared to
HF diet group (Table 2), respectively (P < 0.05). Similarly,
treatment of rosiglitazone group, T-Cho and LDL-c were
significantly lower than those levels of HF diet group. Be-
side the plasma levels of HDL-c levels in RGPM 2 group
increased compared to HF group (P < 0.05) (Table 2).
Similar to the plasma lipid levels, the leptin and
CRP levels were significantly increased in HF diet
group compared to control group. However, treatment
of RGPM groups, especially RGPM 2 group showed
significantly decreased those levels compared to HF
group (Table 3). Furthermore, although there was no
significant difference of GOT levels in HF diet group
compared to control group, treatment of RGPM 2
group showed significantly decreased the levels of
GOT compared to HF group. Similarly, treatment of
rosiglitazone was showed similar results with RGPM
groups.
Effect of RGPM onbloodglucoselevel and oral glucose
tolerance test
Non-fasting blood glucose levels were significantly in-
creased in HF diet rats compared to control group at the
8 weeks. There was no significant change of blood glu-
cose levels between HF group and rosiglitazone, RGPM
groups (Table 3).
Oral glucose tolerance test was carried out to check
insulin resistance in high-fructose diet rats after 8 weeks.Table 3 Effect of RGPM on plasma parameters
Groups Control HF
GOT (IU/L) 9.7 ± 12.5 138.7 ± 4.7
GPT (IU/L) 22.3 ± 4.5 30.0 ± 3.0
Leptin (ng/ml) 2.42 ± 0.1 5.21 ± 0.2 **
CRP (mg/ml) 0.25 ± 0.01 0.30 ± 0.01**
Blood glucose (mg/dl) 143.3 ± 0.9 156.5 ± 34*
Values were expressed as mean ± S.E. (n = 10). **p < 0.01 vs. Cont.; #p < 0.05, ##p < 0.
rosiglitazone, HF + RGPM high fructose diet with Red ginseng and Polygoni Multiflor
transaminase, CRP C-reactive proteinThe results showed that HF group maintained the
significant increasein blood glucose levels at 30, 60,
90 and 120 min (P < 0.05), respectively. However, the
plasma glucose levels in treatment of RGPM 2 group
was significantly decreased at 30, 60 and 120 min as
compared to HF group (P < 0.05) (Fig. 2a). Similarly,
treatment of rosiglitazone group was significantly de-
creased at 30, 60, 90 and 120 min as compared to
HF group. Moreover, area analysis (AUC) showed that
HF diet group significantly increased compared to
control group. However, treatment of rosiglitazone
and RGPM groups were significantly decreased than
that of HF group (Fig. 2b).Effect of RGPM on blood pressure
At the beginning of the experimental feeding period, the
levels of systolic blood pressurein all groups were ap-
proximately 115 ~ 125 mmHg as investigated by the tail-
cuff technique. After 8 weeks, systolic blood pressure of
HF group was significantly increased than that of control
group (P < 0.01). However, treatment of RGPM group-
swassignificantly decreased than that of HF group during
all experimental period (P < 0.01) (Fig. 3a). Similarly,
treatment of rosiglitazone was showed similar results
with RGPM groups. In addition, the protein expression
of ET-1 level was increased in the HF diet group com-
pared to control group. However, treatment of RGPM
groups was significantly decreased expression levels of
protein compared to HF group (Fig. 3b).HF
Ros. RGPM 1 RGPM 2
54.5 ± 6.9## 100.5 ± 9.8 91.5 ± 1.9 ##
15.0 ± 0.9 25.3 ± 1.4 27.8 ± 1.3
2.85 ± 0.2## 2.98 ± 0.5# 3.51 ± 0.4#
0.24 ± 0.01# 0.22 ± 0.02# 0.15 ± 0.01##
144.0 ± 3.1 148.8 ± 4.4 146.8 ± 1.5
01 vs HF. Abbreviations: HF high fructose, HF + Ros. high fructose diet with
i Radix, GOT glutamic-oxaloacetic transaminase, GPT glutamic-pyruvic
Fig. 2 Effect of an RGPM on oral glucose tolerance test (a) and area under the glucose curve (b). Values were expressed as mean ± S.E. (n = 10).
*p < 0.05, **p < 0.01 vs. Cont.; #p < 0.05, ##p < 0.01 vs HF. Abbreviations: HF high fructose, HF + Ros. high fructose diet with rosiglitazone, HF + RGPM
high fructose diet with Red ginseng and PolygoniMultiflori Radix
Fig. 3 Effects of RGPM on systolic blood pressure (a) and expression of ET-1 (b) immunereactivity in aortic tissues of HF diet rats. Representative
immunohistochemistry (magnification × 400) and quantifications are shown. Values were expressed as mean ± S.E. (n = 10 at (a), n = 4 at (b)).
**p < 0.01 vs Cont.; #p < 0.05, ##p < 0.01 vs HF
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molecules, PPAR-γ and ET-1 in aorta
Immunohistochemistry was performed to determine the
direct expression of adhension molecules in the aortic
wall. Adhension molecules expression such as VCAM-1
and E-selectin were increased in the HF diet group (P <
0.01). However, treatment of RGPM groups was signifi-
cantly decreased expression levels of protein (VCAM-1
and E-selectin, P < 0.05) (Fig. 4). Similarly, treatment of
rosiglitazone was showed similar results with RGPM
groups.
The protein expression of VCAM-1, ICAM-1, E-
selectinand PPAR-γ in the descending aortas of all
groups of rats was examined by Western blot analysis.
Expression of adhension molecules (VCAM-1, ICAM-1
and E-selectin) levels were increased in the HF diet
group compared to control group. However, treatment
of RGPM groups was significantly decreased expression
levels of protein compared to HF group (Fig. 5). More-
over, we examined the expression of PPAR-γ levels to
evaluate vascular endothelial function and inflammation.Fig. 4 Effects of RGPM on VCAM-1 (upper) and E-selectin (middle) immun
(magnification × 400) and quantifications are shown (lower). Values were exprThe PPAR-γ protein levels decreased in the HF diet
group compared to control group. However, RGPM
groups were recovered expression levels of protein com-
pared to HF group (Fig. 4). Similarly, treatment of rosi-
glitazone was showed similar results with RGPM groups.
Effect of RGPM on the hepatic lipids
To investigate the existence of fat accumulation of liver
in all experimental groups, we prepared frozen section
of liver and stained with Oil red O. Lipid droplets were
detected in HF diet groups. However, treatment of
RGPM groups showed the number of lipid droplets sig-
nificantly decreased compared to HF diet group (Fig. 6).
Especially, treatment of RGPM 2 was more effectively
suppressed lipid accumulation. Treatment of rosiglita-
zone was showed similar results with RGPM groups.
Discussion
Herb, Acupuncture and Natural Medicine (HAN), one
of the most ancient and revered forms of healing, has
been used to diagnose, treat, and prevent disease fororeactivity in aortic tissues of HF diet rats. Representative figure
essed as mean ± S.E. (n = 4). **p < 0.01 vs Cont.; #p < 0.05, ##p < 0.01 vs HF
Fig. 5 Effect of RGPM on the expression of adhension molecules and PPAR-γ in the aorta (a) and MCP-1 in the liver (b) of HF diet rats. Each
electrophoretogram is representative of the results from three individual experiments. Values were expressed as mean ± S.E. (n = 4). **p < 0.01 vs Cont.;
#p < 0.05, ##p < 0.01 vs HF
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effective means of overcoming disease. Red ginseng and
Polygoni Multiflori Radix, are well-known widely used
traditional medicinal herb specifically for promoting
blood circulation to maintain body homeostasis [21].
Fructose is a lipogenic component, its consumption
promotes the development of atherogenic lipid profile
and elevation of postprandial hypertriglycemia [23, 24].
In addition, HF diet animals develop hypertriglyc-
eridemia, obesity, impaired glucose tolerance, fatty liver,
increased SBP and vascular remodeling [25, 26]. Here
we provided the first evidence for the beneficial effect of
the combination with Red ginseng and Polygoni Multi-
flori Radix on metabolic disordersin high fructose-
induced metabolic syndrome rat model. Several studies
already reported Red ginseng has beneficial effects
against obesity, hyperglycemia [27, 28]. Moreover, red
ginseng also has beneficial effective anti-inflammatory
therapeutic for the atherosclerosis [29]. In addition,some studies already reported Polygoni Multiflori Radix
regulates lipid homeostasis and fat metabolism [30, 31]. In
this case, we hypothesized that the combination with Red
ginseng and Polygoni Multiflori Radix shows a higher syn-
ergies effect of prevention of metabolic syndrome, such as
hypertension, obesity and hyperlipidemia et al.
The development of leptin resistance classically has
been characterized by increased body fat and elevated
circulating leptin levels [32]. In present study, HF diet
increased of leptin level, and induced development of
leptin resistance. Also, HF diet increased body weight
and adipocyte size. However, treatment RGPM improved
leptin resistance with the amelioration of down regula-
tion of body weight and adipocyte size. These results
suggest that RGPM may be useful to suppress the devel-
opment of leptin resistance leading to obesity. Recently
there is a strong correlation between low activation state
of AMPK with metabolic disorder associated with insu-
lin resistance, fat deposition and dyslipidemia [33, 34]. It
Fig. 6 Representative microscopic photographs of Oil red O stained section of the liver in HF diet rat. Representative Oil red O staining
(magnification × 100) and quantifications are shown. Values were expressed as mean ± S.E. (n = 4). **p < 0.01 vs Cont.; ##p < 0.01 vs HF
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present study maybe associated with impaired leptin-
mediated decrease in AMPK phospholyation. Although,
we did not examine specific research related energy me-
tabolism as AMPK pathway, we conjectured treatment
of RGPM would be related to several improvements of
metabolic syndrome by activating of AMPK related sig-
nal pathways.
NFALD where triglyceride is stored more than 5 % in
the liver is a status in which fat is accumulated in the
whole liver tissues by insulin resistance, obesity and dys-
lipidemia [35]. It is known that overallmetabolic disor-
derinduces increasing ofoxidative stress, increasing
inflammatory cytokine such as PAI-1 and MCP-1. Also,
it is decreasing secretion of adiponectin which functions
reversely is a cause of atherosclerosis outbreak [36]. In
addition, Dyslipidemia, impaired glucose tolerance and
fatty liver are major features associated with metabolic
syndrome in HF diet rats [37, 38]. Fructose induces
impaired glucose tolerance via the elevation of plasma
triglyceride levels. In addition, previous study demon-
strated that an elevated fructose diet associated with im-
paired glucose tolerance and endothelial dysfunction
precedes the development of hypertension [39]. Im-
paired glucose tolerance plays an important role in the
development of such abnormalities as insulin resistance,
type 2 diabetes and dyslipidemia [40]. HF diet induced
impaired glucose tolerance, dyslipidemia and fatty liver,whereas, treatment RGPM improved impaired glucose tol-
erance with the amelioration of dyslipidemia and fatty
liver. Thus, these results suggest that RGPM may be use-
ful to suppress the development of atherosclerotic lesions
and ameliorated lipid metabolism in metabolic syndrome
model. Although, in the present study did not confirm a
secretion of factor of PAI-1 or adiponectin, it is well
known that CRP is a factor of direct inducer of PAI-1.
This study showed that RGPM decreased of levels of CRP
as well as reduction of weight and size of fat tissues and
increased of leptin sensitivity. In this way, these results
suggest that RGPM that changed fatty metabolism for has
effects to secretion of PAI-1 or adiponectin. Besides, treat-
ment of RGPM suppressed expression of MCP-1 which is
improved of by NFALD induced steatohepatitis.
It is reported that the inflammation index of interior
of body is a predictive progressivefactor of cardiovascu-
lar disease caused by atherosclerosis, metabolic syn-
drome and type 2 diabetes. High-sensitivity CRPis well
known as the most powerful predictive factor of cardio-
vascular disease, which caused an increase of inflamma-
tory cytokine, such as MCP-1. CRP promotes a secretion
of triglyceride and it highly came out from patients of
cardiovascular disease [41]. It is reported that high-
sensitivity CRP induced high blood pressure and pro-
gress of blood vessel inflammation, which is related with
adhesion molecules, ET-1 and inflammatory cytokine in
vascular endothelial of a blood vessel and increased in
Kho et al. BMC Complementary and Alternative Medicine  (2016) 16:98 Page 10 of 11an initial stage of atherosclerosis [42, 43]. In the present
study, RGPM ameliorated vascular inflammation by down-
regulation of ET-1 as well as ICAM-1, VCAM-1 and E-
selectin expression in thoracic aorta. Moreover, RGPM sup-
pressed the levels of CRP in plasma and down-regulated
blood pressure, compatible with the processes of athero-
sclerosis. Therefore, improvement of endothelial function is
predicted to regulate lipid homeostasis [44]. Thus, anti-
hypertension and anti-vascular inflammatory effects of
RGPM contribute to the beneficial effects on endothelial
function and lipid metabolism in metabolic syndrome.
In the present study used rosiglitazone, selective
hypoglycemic agent, as a positive control, which is re-
cently reported that rosiglitazone effect reducing of fat
accumulation, blood pressure and improve vascular in-
flammation in NFALD [45, 46]. In addition, clinical trial
showed that glitazone medicine improved insulin resist-
ance of NASH patients, morphological change and stabi-
lized an index of GPT and GOT [47]. To investigate
compare of damage of liver with aggravation of inflam-
mation, this study measured plasma levels of GPT and
GOT. Treatment of RGPM significantly improved the
levels of GOT. Even though the levels of GPT did not
showed significant difference, judging from the decrease
results speculated that RGPM has effect of an improve-
ment by high fructose induced liver damage.
Conclusions
These results suggest that RGPM ameliorates lipid me-
tabolism, impaired glucose tolerance, hypertension, fatty
liver and obesity in HF diet-induced metabolic syn-
drome, at least in part, via reducing of inflammation.
Therefore, combination of Red ginseng and Polygoni
Multiflori Radix might be a beneficial therapeutic ap-
proach for metabolic syndrome.
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